Make medicines evidence useful where care begins.
In primary care, a medicines improvement has to work inside a demanding day. A review needs preparation. A decision needs clinical judgement. An agreed change needs people who can explain it, introduce it and return to the unresolved questions.
NEUVIOR’s Medicines Intelligence direction begins with those practical demands. Through PHARMORIS, the Medicines Action Layer, we are developing a way to connect an organisational medicines question with the evidence and work that follows. The aim is a more useful decision process for the professionals responsible for care.
In the conversation.
NEUVIOR and our founder’s perspectives have appeared across science, business and technology publications.
Reporting, commentary, letters and podcast appearances | Read each feature for its format and source.
Give the question a place in the working day.
Clinical pharmacists, GPs, pharmacy technicians and practice teams bring different expertise to medicines work. Preparing evidence, clarifying a query and coordinating an agreed action can draw on the same limited capacity as consultations and ongoing care.
A useful proposition starts with the task that repeatedly consumes attention. Where does the team search for information? Which handover needs chasing? What is reconstructed when the case reaches another reviewer? These details identify whether the problem concerns evidence, coordination, resources or a combination. They also establish what a new approach would have to improve to earn a place in the practice.
Understand what the national picture can tell you.
NHSBSA reports 1.30 billion prescription items dispensed in the community in England during 2025/26. That is a measure of community dispensing within Prescription Cost Analysis scope, rather than a count of GP consultations or individual patients.
For a practice or primary care network, the useful question is local. Which medicines task could become clearer, and what would that allow the team to do? National prescribing information can help identify a question, while professional knowledge and the current workflow establish its relevance. The value comes from a defensible next decision and an approach that fits the people who will carry it out.
Keep clinical judgement central.
NHS guidance describes structured medication reviews as comprehensive, evidence-based reviews involving clinicians and patients as partners. Individual needs, preferences and circumstances matter. The number offered depends on clinical-pharmacist capacity.
That context shapes our interest in the organisational work around a medicines change. A proposed PHARMORIS evaluation could examine evidence preparation, professional checking and follow-through. It would not treat an aggregate trend as a reason to change an individual’s treatment. Qualified professionals remain responsible for clinical decisions, and the evaluation question must reflect the actual task and setting. A useful result would explain whether the approach supports their work and where further development is needed.
Make one example concrete.
Consider a practice preparing an organisational review of a prescribing improvement. A pharmacist gathers the relevant material. The prescribing lead examines local suitability. The team then needs to understand training, communication, capacity and any unresolved questions before deciding how to proceed.
A focused evaluation could compare the existing process with a proposed way of organising that evidence and follow-through. It would count preparation, source checking, corrections and coordination. It would also ask whether another qualified person can understand the case without starting again. This is an illustrative evaluation question; the agreed scope would establish the functions and information appropriate to the particular task.
Measure something the team can use.
Our planned evaluation approach begins with competent existing practice. The relevant measures could include evidence quality, total professional effort, queries, rework, clarity of ownership and follow-through. Preparation speed alone would leave too much of the job unexplained.
Include the work introduced by the tool: onboarding, checking, support and keeping the case current. Examine whether the result remains useful across people with different responsibilities. A finding may justify a narrower task, a different workflow or another study. This gives development a practical direction and helps the organisation decide whether the value is worth pursuing.
Bring the primary-care question that keeps returning.
Tell us the medicines task, the people who prepare and review it, and where the work repeatedly gets stuck. Describe your current approach and what a worthwhile improvement would allow the team to do.
A PHARMORIS briefing can then focus on fit: the intended task, the responsible organisation, a useful comparison and the resources a possible evaluation would require. We welcome primary-care professionals and authorised organisational leads who want to examine a real problem together.